by Gevers, T.J. et al.
Department of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands
Department of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands
Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease.
BMC. Nephrol. 2012; 17